168 related articles for article (PubMed ID: 31535659)
1. Effect of stromal cell-derived factor-1/CXCR4 axis in neural stem cell transplantation for Parkinson's disease.
Xu JT; Qian Y; Wang W; Chen XX; Li Y; Li Y; Yang ZY; Song XB; Lu D; Deng XL
Neural Regen Res; 2020 Jan; 15(1):112-119. PubMed ID: 31535659
[TBL] [Abstract][Full Text] [Related]
2. Ginsenoside Rb1 protects dopaminergic neurons from inflammatory injury induced by intranigral lipopolysaccharide injection.
Li DW; Zhou FZ; Sun XC; Li SC; Yang JB; Sun HH; Wang AH
Neural Regen Res; 2019 Oct; 14(10):1814-1822. PubMed ID: 31169200
[TBL] [Abstract][Full Text] [Related]
3. Neural stem cells transplantation combined with ethyl stearate improve PD rats motor behavior by promoting NSCs migration and differentiation.
Huang J; Yi L; Yang X; Zheng Q; Zhong J; Ye S; Li X; Li H; Chen D; Li C
CNS Neurosci Ther; 2023 Jun; 29(6):1571-1584. PubMed ID: 36924304
[TBL] [Abstract][Full Text] [Related]
4. Neural stem cell transplantation and melatonin treatment in a 6-hydroxydopamine model of Parkinson's disease.
Sharma R; McMillan CR; Niles LP
J Pineal Res; 2007 Oct; 43(3):245-54. PubMed ID: 17803521
[TBL] [Abstract][Full Text] [Related]
5. Transplantation of bone marrow stromal cells containing the neurturin gene in rat model of Parkinson's disease.
Ye M; Wang XJ; Zhang YH; Lu GQ; Liang L; Xu JY; Chen SD
Brain Res; 2007 Apr; 1142():206-16. PubMed ID: 17336273
[TBL] [Abstract][Full Text] [Related]
6. Treadmill exercise suppresses nigrostriatal dopaminergic neuronal loss in 6-hydroxydopamine-induced Parkinson's rats.
Yoon MC; Shin MS; Kim TS; Kim BK; Ko IG; Sung YH; Kim SE; Lee HH; Kim YP; Kim CJ
Neurosci Lett; 2007 Aug; 423(1):12-7. PubMed ID: 17644250
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic effects of intranigral transplantation of mesenchymal stem cells in rat models of Parkinson's disease.
Chen D; Fu W; Zhuang W; Lv C; Li F; Wang X
J Neurosci Res; 2017 Mar; 95(3):907-917. PubMed ID: 27617772
[TBL] [Abstract][Full Text] [Related]
8. Dissociation between dopaminergic response and motor behavior following intrastriatal, but not intravenous, transplant of bone marrow mononuclear stem cells in a mouse model of Parkinson's disease.
Calice da Silva C; Azevedo BN; Machado DC; Zimmer ER; Martins LAM; da Costa JC
Behav Brain Res; 2017 May; 324():30-40. PubMed ID: 28167338
[TBL] [Abstract][Full Text] [Related]
9. Embryonic stem cell-derived L1 overexpressing neural aggregates enhance recovery in Parkinsonian mice.
Cui YF; Hargus G; Xu JC; Schmid JS; Shen YQ; Glatzel M; Schachner M; Bernreuther C
Brain; 2010 Jan; 133(Pt 1):189-204. PubMed ID: 19995872
[TBL] [Abstract][Full Text] [Related]
10. GDNF-secreting mesenchymal stem cells provide localized neuroprotection in an inflammation-driven rat model of Parkinson's disease.
Hoban DB; Howard L; Dowd E
Neuroscience; 2015 Sep; 303():402-11. PubMed ID: 26166730
[TBL] [Abstract][Full Text] [Related]
11. Preconditioning of bone marrow-derived mesenchymal stromal cells by tetramethylpyrazine enhances cell migration and improves functional recovery after focal cerebral ischemia in rats.
Li L; Chu L; Fang Y; Yang Y; Qu T; Zhang J; Yin Y; Gu J
Stem Cell Res Ther; 2017 May; 8(1):112. PubMed ID: 28499457
[TBL] [Abstract][Full Text] [Related]
12. Verbascoside promotes the regeneration of tyrosine hydroxylase-immunoreactive neurons in the substantia nigra.
Liang JQ; Wang L; He JC; Hua XD
Neural Regen Res; 2016 Jan; 11(1):101-6. PubMed ID: 26981096
[TBL] [Abstract][Full Text] [Related]
13. Are human dental papilla-derived stem cell and human brain-derived neural stem cell transplantations suitable for treatment of Parkinson's disease?
Yoon HH; Min J; Shin N; Kim YH; Kim JM; Hwang YS; Suh JK; Hwang O; Jeon SR
Neural Regen Res; 2013 May; 8(13):1190-200. PubMed ID: 25206413
[TBL] [Abstract][Full Text] [Related]
14. Intracerebroventricular transplanted bone marrow stem cells survive and migrate into the brain of rats with Parkinson's disease.
Gu P; Zhang Z; Cui D; Wang Y; Ma L; Geng Y; Wang M
Neural Regen Res; 2012 May; 7(13):978-84. PubMed ID: 25722685
[TBL] [Abstract][Full Text] [Related]
15. Hyperbaric oxygen improves functional recovery of rats after spinal cord injury via activating stromal cell-derived factor-1/CXC chemokine receptor 4 axis and promoting brain-derived neurothrophic factor expression.
Meng XL; Hai Y; Zhang XN; Wang YS; Liu XH; Ma LL; Yue R; Xu G; Li Z
Chin Med J (Engl); 2019 Mar; 132(6):699-706. PubMed ID: 30855350
[TBL] [Abstract][Full Text] [Related]
16. P2X4 receptor participates in autophagy regulation in Parkinson's disease.
Zhang X; Wang J; Gao JZ; Zhang XN; Dou KX; Shi WD; Xie AM
Neural Regen Res; 2021 Dec; 16(12):2505-2511. PubMed ID: 33907041
[TBL] [Abstract][Full Text] [Related]
17. ret receptor tyrosine kinase immunoreactivity is altered in glial cell line-derived neurotrophic factor-responsive neurons following lesions of the nigrostriatal and septohippocampal pathways.
Araujo DM; Hilt DC; Miller PJ; Wen D; Jiao S; Lapchak PA
Neuroscience; 1997 Sep; 80(1):9-16. PubMed ID: 9252216
[TBL] [Abstract][Full Text] [Related]
18. Chronic low-dose melatonin treatment maintains nigrostriatal integrity in an intrastriatal rotenone model of Parkinson's disease.
Carriere CH; Kang NH; Niles LP
Brain Res; 2016 Feb; 1633():115-125. PubMed ID: 26740407
[TBL] [Abstract][Full Text] [Related]
19. Altered melatonin MT
Kang NH; Carriere CH; Bahna SG; Niles LP
Brain Res; 2016 Dec; 1652():89-96. PubMed ID: 27693415
[TBL] [Abstract][Full Text] [Related]
20. Astrocytes retrovirally transduced with BDNF elicit behavioral improvement in a rat model of Parkinson's disease.
Yoshimoto Y; Lin Q; Collier TJ; Frim DM; Breakefield XO; Bohn MC
Brain Res; 1995 Sep; 691(1-2):25-36. PubMed ID: 8590062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
